Smiths Detection BioFlash Detects Airborne COVID
Smiths Detection reports its BioFlash air sampler can detect airborne SARS-CoV-2 variants by collecting aerosols and identifying dangerous pathogens using sensitive, specific and rapid detection in near-real time without lab analysis.
Detection covers the Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant (B1.617.1), Delta (B.1.617.2) and Delta plus variant (B.1.617.2.1). The company is currently confirming the ability to detect the Lambda variant, with results likely available in Autumn.
In January, Smiths Detection announced that BioFlash was capable of detecting airborne SARS-CoV-2 by the United States Army of Medical Research Institute of Infectious Diseases (USAMRIID), and has been successfully used by several universities to stop the spread of COVID-19 following airborne detection in several campus buildings.
“It has been a great asset to have this equipment at UMBC. As everyone knows, you need a layered protection strategy to combat COVID. BioFlash is easy and fast to use which makes it a critical part of our mitigation strategy to help prevent transmission,” said Mike Pound, of University of Maryland.